Dow Down0.62% Nasdaq Down1.14%

Novavax, Inc. (NVAX)

-NasdaqGS
4.30 Down 0.12(2.71%) 4:00PM EDT
|After Hours : 4.30 0.00 (0.00%) 4:30PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 8,259   7,462   8,748   4,802  
Cost of Revenue5,102  3,021  2,603  2,275  
Gross Profit 3,157   4,441   6,145   2,527  
Operating Expenses
Research Development15,202  14,518  16,319  13,948  
Selling General and Administrative5,806  4,308  4,079  3,858  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (17,851) (14,385) (14,253) (15,279)
Income from Continuing Operations
Total Other Income/Expenses Net38  627  230  44  
Earnings Before Interest And Taxes(17,813)(13,758)(14,023)(15,235)
Interest Expense51  52  28  64  
Income Before Tax(17,864)(13,810)(14,051)(15,299)
Income Tax Expense -   -  3   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(17,864)(13,810)(14,054)(15,299)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (17,864) (13,810) (14,054) (15,299)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (17,864) (13,810) (14,054) (15,299)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.